1-2 of 2
D.H. Zermann
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Management of Germ Cell Tumours of the Testes in Adult Patients: German Clinical Practice Guideline, PART II – Recommendations for the Treatment of Advanced, Recurrent, and Refractory Disease and Extragonadal and Sex Cord/Stromal Tumours and for the Management of Follow-Up, Toxicity, Quality of Life, Palliative Care, and Supportive Therapy

Open Access
Subject Area:
Further Areas
Sabine Kliesch, Stefanie Schmidt, Doris Wilborn, Clemens Aigner, Walter Albrecht, Jens Bedke, Matthias Beintker, Dirk Beyersdorff, Carsten Bokemeyer, Jonas Busch, Johannes Classen, Maike de Wit, Klaus-Peter Dieckmann, Thorsten Diemer, Anette Dieing, Matthias Gockel, Bernt Göckel-Beining, Oliver W. Hakenberg, Axel Heidenreich, Julia Heinzelbecker, Kathleen Herkommer, Thomas Hermanns, Sascha Kaufmann, Marko Kornmann, Jörg Kotzerke, Susanne Krege, Glen Kristiansen, Anja Lorch, Arndt-Christian Müller, Karin Oechsle, Timur Ohloff, Christoph Oing, Ulrich Otto, David Pfister, Renate Pichler, Heinrich Recken, Oliver Rick, Yvonne Rudolph, Christian Ruf, Joachim Schirren, Hans Schmelz, Heinz Schmidberger, Mark Schrader, Stefan Schweyer, Stefanie Seeling, Rainer Souchon, Christian Winter, Christian Wittekind, Friedemann Zengerling, D.H. Zermann, Roger Zillmann, Peter Albers
Journal: Urologia Internationalis
Urol Int (2021) 105 (3-4): 181–191.
https://doi.org/10.1159/000511245
Published Online: 22 January 2021
View article titled, Management of Germ Cell Tumours of the Testes in Adult Patients: German Clinical Practice Guideline, PART II – Recommendations for the Treatment of Advanced, Recurrent, and Refractory Disease and Extragonadal and Sex Cord/Stromal Tumours and for the Management of Follow-Up, Toxicity, Quality of Life, Palliative Care, and Supportive Therapy
Open the PDF for Management of Germ Cell Tumours of the Testes in Adult Patients: German Clinical Practice Guideline, PART II – Recommendations for the Treatment of Advanced, Recurrent, and Refractory Disease and Extragonadal and Sex Cord/Stromal Tumours and for the Management of Follow-Up, Toxicity, Quality of Life, Palliative Care, and Supportive Therapy in another window
Journal Articles

Increased Transforming Growth Factor β1 Plasma Level in Patients with Renal Cell Carcinoma:A Tumor-Specific Marker?

Available to Purchase
Subject Area:
Further Areas
H. Wunderlich, T. Steiner, H. Kosmehl, U. Junker, D. Reinhold, O. Reichelt, D.H. Zermann, J. Schubert
Journal: Urologia Internationalis
Urol Int (1998) 60 (4): 205–207.
https://doi.org/10.1159/000030255
Published Online: 14 August 1998
View article titled, Increased Transforming Growth Factor β1 Plasma Level in Patients with Renal Cell Carcinoma:A Tumor-Specific Marker?
Open the PDF for Increased Transforming Growth Factor β1 Plasma Level in Patients with Renal Cell Carcinoma:A Tumor-Specific Marker? in another window